Clinuvel Pharmaceuticals submits NDA for SCENESSE to Health Canada, aiming to treat rare genetic disorder

Clinuvel Pharmaceuticals has filed a New Drug Submission to Health Canada for its innovative therapy, SCENESSE, marking a potential breakthrough for Canadian patients suffering from ... Read More